Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

Nanjing Legend Raises $150 Million for Cell Therapies in an A Round/Pre-IPO Financing

Legend, a Nanjing CAR-T Biotech, Files for a US IPO

RootPath Raises $11 Million for Personalized TCR/CAR-T Solid Tumor Treatments

Innovative Cellular Therapeutics Raises $28.6 Million for Next-Gen CAR-T Drugs

Suzhou Ribo Raises $29 Million for siRNA Drug Development

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China